Literature DB >> 23827181

Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands.

Madichaba P Chelopo1, Sachin A Pawar, Mxolisi K Sokhela, Thavendran Govender, Hendrik G Kruger, Glenn E M Maguire.   

Abstract

Ruthenium complexes offer potential reduced toxicity compared to current platinum anticancer drugs. 1,2,3,4-tetrahydrisoquinoline amino alcohol ligands were synthesised, characterised and coordinated to an organometallic Ru(II) centre. These complexes were evaluated for activity against the cancer cell lines MCF-7, A549 and MDA-MB-231 as well as for toxicity in the normal cell line MDBK. They were observed to be moderately active against only the MCF-7 cells with the best IC₅₀ value of 34 μM for the cis-diastereomeric complex C4. They also displayed excellent selectivity by being relatively inactive against the normal MDBK cell line with SI values ranging from 2.3 to 7.4.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  1,2,3,4-tetrahydrisoquinoline; 1,8- diazabicycloundec-7-ene; A549; ATR; Anticancer; Cbz-Cl; DBU; DIPEA; ESI-QTOF; FA; HRMS; IC(50); LiAlH(4); MCF-7; MDA-MB-231; MDBK; MDR; Madin–Darby bovine kidney; Me(2)SO(4); Michigan cancer foundation-7; N,N; N,N-diisopropylethylamine; N,O; N-donor; Na(2)SO(4); NaBH(4); Pd/C; R(f); Ru(II); Ruthenium; SAR; SI; SOCl(2); TBDMS; TEA; TIQ; Tetrahydroisoquinoline; amino alcohol; atm; atmosphere; attenuated total reflectance; benzyl chloroformate; diamine; dimethyl sulfate; electrospray ionization quadrupole time of flight; formic acid; half maximal inhibitory concentration; high resolution mass spectrometry; human breast epithelial adenocarcinoma; human lung epithelial adenocarcinoma; lithium aluminium hydride; micro molar; multidrug resistance; nitrogen donor; palladium on carbon; part per million; ppm; retention factor; ruthenium(II); selectivity index; sodium borohydride; sodium sulfate; structure activity relationship; tert-butyl dimethyl silyl; thionyl chloride; triethylamine; μM

Mesh:

Substances:

Year:  2013        PMID: 23827181     DOI: 10.1016/j.ejmech.2013.05.048

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

Review 1.  The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Authors:  Leli Zeng; Pranav Gupta; Yanglu Chen; Enju Wang; Liangnian Ji; Hui Chao; Zhe-Sheng Chen
Journal:  Chem Soc Rev       Date:  2017-10-02       Impact factor: 54.564

2.  Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation.

Authors:  Wanessa Carvalho Pires; Benedicto Augusto Vieira Lima; Flávia de Castro Pereira; Aliny Pereira Lima; Francyelli Mello-Andrade; Hugo Delleon Silva; Monize Martins da Silva; Legna Colina-Vegas; Javier Ellena; Alzir A Batista; Elisângela de Paul Silveira-Lacerda
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

3.  Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity.

Authors:  Anna Gatti; Abraha Habtemariam; Isolda Romero-Canelón; Ji-Inn Song; Bindy Heer; Guy J Clarkson; Dominga Rogolino; Peter J Sadler; Mauro Carcelli
Journal:  Organometallics       Date:  2018-02-20       Impact factor: 3.876

4.  D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.

Authors:  Abdulrahman I Almansour; Raju Suresh Kumar; Natarajan Arumugam; Giulia Bianchini; J Carlos Menéndez; Faruq Mohammad; Kotresha Dupadahalli; Mohammad Altaf
Journal:  Biomed Res Int       Date:  2019-11-13       Impact factor: 3.411

5.  A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway.

Authors:  Yu Lu; Di Zhu; Lin Gui; Yuanming Li; Wenjing Wang; Jiawang Liu; Yuji Wang
Journal:  J Nanobiotechnology       Date:  2021-04-23       Impact factor: 10.435

6.  A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs.

Authors:  Maria Noelia Chao; Jean-Michel Chezal; Eric Debiton; Damien Canitrot; Tiffany Witkowski; Sophie Levesque; Françoise Degoul; Sébastien Tarrit; Barbara Wenzel; Elisabeth Miot-Noirault; Audrey Serre; Aurélie Maisonial-Besset
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-28

7.  Novel Zinc(II) Complexes [Zn(atc-Et)₂] and [Zn(atc-Ph)₂]: In Vitro and in Vivo Antiproliferative Studies.

Authors:  Erica de O Lopes; Carolina G de Oliveira; Patricia B da Silva; Carlos E Eismann; Carlos A Suárez; Amauri A Menegário; Clarice Q F Leite; Victor M Deflon; Fernando R Pavan
Journal:  Int J Mol Sci       Date:  2016-05-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.